February 2023: OSSIOfiber Compression Staple, the latest product by OSSIO, Inc., an orthopaedic fixation technology company, is the stepping stone to becoming the gold standard in orthopaedic fixation. These staples allow surgeons to apply stronger compression during surgery.
January 2023: Organon has invested in Claria Medical, a global women’s healthcare company and a privately-held medical device firm that is developing an investigational device used in minimally invasive laparoscopic hysterectomies. The agreement also gives Organon the option to buy Claria Medical. Claria System - an initial investigational device uses an intelligent uterine containment and extraction system for better hysterectomy procedures involving patients and doctors alike.
October 2022 saw Medtronic—a leader in healthcare technology globally—making some important announcements concerning global market entry and application product approvals for its new HugoTM robotic-assisted surgery (RAS) system.
Olympus Corporation ("Olympus") introduced VISERA ELITE III – its newest surgical visualisation platform designed specifically for endoscopic surgeries across multiple medical disciplines – at the beginning of September 2022.
Virtual Incision Corporation will see its MIRA Platform demonstrated on International Space Station (ISS) in August 2024, with capabilities being tested in August of 2022. (ISS)
In August 2022, Virtual Incision Corporation announced that it would test run its MIRA Platform in space by sending it on a technological demonstration mission through the International Space Station (ISS) in 2024.
In June of this year, Xenco Medical launched Multilevel CerviKit – an extension of their innovative single-use cervical spine technology to incorporate the full line-up of implants and single-use instruments required for two-, three- or four-level prior cervical spine procedures, increasing their device portfolio for ASCs. The kit was cleared by the US Food and Drug Administration.
POWER SEAL enhanced bipolar surgical energy devices were introduced by Olympus in September 2021 to strengthen their surgical portfolio.
In 2021, SS Innovations declared the commercial release of India's first general robotic surgery equipment in the following 4-6 months. In addition to this, Medrobotics Corp. received funding of USD 20 million in February 2017 for the huge expansion in novel surgical applications and for developing the next-generation Flex Robotic System.
Indian-based firm SS Innovations made a similar announcement in February 2021 that it will launch India's first general robotic surgery equipment within next four to six months.
The general surgical devices market is segmented on the basis of type, product, application, and end-user.
On the basis of type, the global general surgical devices market can be segmented into disposable surgical supplies, open surgery instrument, energy-based and powered instrument, minimally invasive surgery instruments, medical robotics and computer-assisted surgery devices, and others.
The disposable surgical supplies are segmented into surgical non-woven, examination and surgical gloves, general surgery procedural kits, needles and syringes, venous access catheters, and others. The surgical non-woven segment is further divided into disposable surgical masks, surgical drapes, surgical caps, surgical gowns, and others.
The open surgery instrument is segmented into retractor, dilator, and catheters. The energy-based and powered instruments are segmented into powered staplers and drill system. The minimally invasive surgery instruments are divided into laparoscope and organ retractor. The medical robotics and computer-assisted surgery devices are divided into adhesion prevention products and others.
On the basis of product, the general surgical devices market can be segmented into handheld devices, laparoscopic devices, electrosurgical devices, wound closure devices, trocars and access devices, and others.
On the basis of application, the general surgical devices market can be segmented into orthopedic surgery, cardiology, ophthalmology, wound care, audiology, thoracic surgery, urology and gynecology surgery, plastic surgery, neurosurgery, and others.
On the basis of end-user, the general surgical devices market can be segmented into hospitals, clinics, diagnostic centers, academic institutes, research centers, and others.
The general surgical devices market consists of regions, namely, America, Europe, Asia Pacific, and the Middle East and Africa.
Americas dominated the general surgical devices market owing to the increasing number of surgical procedures, the presence of key players, favorable reimbursement policies, and numerous initiatives undertaken by the government to provide training sessions and access to advanced devices for physicians.
As per an article published by Time, Inc., until June 2017 there were more than 4,100 da Vinci units installed globally. This includes 2,703 in the U.S., 698 units in Europe, 538 units in Asia, and 210 units in the rest of the world. For instance, in April 2017, Intuitive Surgical, Inc. received the CE mark approval in Europe for the da Vinci X Surgical System that offers robotic-assisted surgeries at a lower cost for surgeons and hospitals.
Asia Pacific is anticipated to grow at a maximum pace during the forecast period due to rising investments along with the regional expansion. For instance, in February 2014, CryoLife, Inc. established a new subsidiary in the Asia Pacific region. This expansion will increase the presence of the subsidiary in the general surgery devices market in the Asia Pacific region.
The Middle East and Africa has the potential to emerge as a production hub for medical devices and large-scale development. The key factor contributing to this transformation is the low cost of product development in this region.
Recent Development
Key Players
Some of key the players in the general surgical devices market are
Intended Audience
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â 17.81 billion |
| Â Â CAGR | Â Â 8.6% (2023-2032) |
| Â Â Base Year | Â Â 2021 |
| Â Â Forecast Period | Â Â 2023-2032 |
| Â Â Historical Data | Â Â 2020 |
| Â Â Forecast Units | Â Â Value (USD Million) |
| Â Â Report Coverage | Â Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Â Â Type, Product, Application, and End-User |
| Â Â Geographies Covered | Â Â North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
|   Key Vendors |   Johnson & Johnson Services, Inc. (U.S.), Erbe Elektromedizin GmbH (Germany), Conmed Corporation (U.S.), Integra LifeSciences (U.S.), Smith & Nephew (U.S.), 3M Healthcare (U.S.), CareFusion Corporation (U.S.), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), Boston Scientific Corporation (U.S.), Medtronic Plc. (U.S.), Stryker Corporation (U.S.), Cadence Inc. (U.S.), Maquet Holding B.V. & CO. KG. (Germany), Olympus Corporations (U.S.), Grifols (Spain), Ortho-Clinical Diagnostics, Inc. (U.S.), SOFINA s.a (Biomérieux) (U.S.), Siemens Healthcare GmbH (Germany), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Accuray Incorporated (U.S.), Intuitive Surgical Inc. (U.S.), Medrobotics Corporation (U.S.), TransEnterix Surgical (U.S.), Meere Company (U.S.), Titan Medical (Canada), Verb Surgical (U.S.), Virtual Incision Corporation (U.S.), and others. |
|   Key Market Opportunities | · High demand for disposable supplies· Increasing awareness about diseases transmitted through surgical devices· Government regulations ensuring safety in surgical procedures |
|   Key Market Drivers | · Technological advancement in general surgical devices· Rising demand for minimally invasive devices· Growing incidence of injuries and accidents· Increasing healthcare expenditures in emerging economies |
General Surgical Devices Market Highlights:
Frequently Asked Questions (FAQ) :
On the basis of type, the General Surgical Devices Market can be segmented into disposable surgical supplies, open surgery instrument, energy-based and powered instrument, minimally invasive surgery instruments, medical robotics and computer-assisted surgery devices, and others.
Market is expected to exhibit a strong 8.6% CAGR over the forecast period from 2023 to 2032.
Growing demand for surgical procedures is the major driver for the General Surgical Devices Market.
Americas dominate the General Surgical Devices Market.
Leading players in the General Surgical Devices Market include Integra LifeSciences, Conmed Corporation, and 3M Healthcare, among others.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
